Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-25

FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for escitalopram (generic) under an ANDA, confirming the availability of a generic escitalopram pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITSLOPRAM)